Journal of Clinical Lipidology
Publisher: Elsevier · ISSN 1933-2874 · 88 articles
- A novel VPS4A variant drives lipotoxicity underlying CIMDAG syndrome
- Two cases of late-onset lysosomal acid lipase deficiency with Achilles tendon thickening
- Bempedoic acid vs ezetimibe in routine care: Observation time, residual confounding, and endpoint interpretation
- Methodological considerations in real-world comparative effectiveness research: insights from the BEYOND-REAL study
- HDL function after PCSK9 inhibition: Assay scope, normalization, and clinical interpretation
- Revisiting the paradoxical effects of artichoke leaf extract in severe obesity
- Long-term knowledge and screening outcomes following a gamified lipoprotein(a) curriculum for internal medicine residents at a large academic ambulatory practice
- Lipoprotein(a) management simplified: The National Lipid Association lipid simplified series
- Lipoprotein(a): Particle vs mass and prevalent cardiovascular disease in the cardiovascular risk in Young Finns study population
- Reduced LDL receptor expression and LDL uptake in lymphoblastoid cells from a patient with cholesteryl ester storage disease
- Lipoprotein(a) identifies premature coronary artery disease in patients with low LDL-cholesterol: A large multicenter cohort study
- Real-world threshold-based eligibility for emerging lipoprotein(a)-targeted therapies in chronic and acute coronary syndrome
- Reply to: Temporal concerns regarding the proposed mediation between remnant cholesterol and gestational diabetes
- Implementing genetics-based cascade testing for familial hypercholesterolemia in Colombia: Results from a pilot study and implications for national screening strategies
- To test or not to test: Indications and actionability in lipid genetics
- NST-1024 for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 28-day clinical trial
- LDL-C management simplified: The National Lipid Association lipid simplified series
- New Horizons for Lipoprotein(a)
- Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia
- Healthcare costs of recurrent acute pancreatitis hospitalizations
- Efficacy and safety of olezarsen in patients with vs without baseline fibrate use
- Validation of two familial chylomicronemia syndrome clinical diagnosis scores in a cohort of molecularly defined patients
- Efficacy and safety of add-on bempedoic acid on maximal dose of rosuvastatin and ezetimibe in patients with established coronary artery disease (ADDBEMPERE study)
- Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry
- Durable lipid-lowering beyond 10 years with lomitapide in homozygous familial hypercholesterolemia: A real-world experience in Taiwan
- Temporal aspects and implications of the measurement of lipoprotein(a) in patients with acute myocardial infarction
- Isocaloric macronutrient and fat types substitution and lipid profile: A cross-sectional analysis of the Amol Cohort Study
- Circulating long and very long-chain saturated fatty acids and heart failure: Results from a large US cohort study
- Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial
- Sitosterolemia as a treatable and underrecognized cause of chronic thrombocytopenia beyond ITP: A targeted screening study